Maternally derived antibodies serve as crucial early-life protection for piglets against infectious diseases, including swine influenza A virus (SwIAV). However, these same protective antibodies create significant challenges for vaccination programs by interfering with vaccine-induced immune responses, thereby reducing vaccine effectiveness. This interference has been well-documented with whole inactivated virus (WIV) vaccines against SwIAV, creating an urgent need for innova